As of the latest SEC filings, Summit Therapeutics Inc. (SMMT) is held by 188 institutional funds. The largest fund shareholder is T. Rowe Price Health Sciences Fund, Inc. (PRHSX), holding an estimated $112,780,204.08 in market value, representing 1.04% of its portfolio.
Funds holding Summit Therapeutics Inc. (SMMT)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- SMMT
- CIK:
- 0001599298
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 1.04% | $112,780,204.08 | 5,948,323 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 1.24% | $92,267,854.08 | 4,866,448 | Mar 31, 2026 | May 28, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $71,197,719.84 | 3,755,154 | Mar 31, 2026 | May 28, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.03% | $50,814,790.80 | 2,680,105 | Mar 31, 2026 | May 28, 2026 |
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.05% | $39,529,606.83 | 2,382,737 | Feb 28, 2026 | Apr 24, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.04% | $32,583,252.96 | 1,718,526 | Mar 31, 2026 | May 28, 2026 |
|
VISVX
VANGUARD SMALL-CAP VALUE INDEX FUND
|
ETF | Vanguard | 0.05% | $32,374,939.44 | 1,707,539 | Mar 31, 2026 | May 28, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.34% | $18,069,313.71 | 1,089,169 | Feb 28, 2026 | Apr 24, 2026 |
|
FSPHX
Select Health Care Portfolio
|
MF | Fidelity | 0.27% | $16,590,000.00 | 1,000,000 | Feb 28, 2026 | Apr 24, 2026 |
|
SHSKX
BlackRock Health Sciences Opportunities Portfolio
|
MF | BlackRock / iShares | 0.23% | $15,331,615.32 | 924,148 | Feb 27, 2026 | Apr 24, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.19% | $15,158,083.92 | 799,477 | Mar 31, 2026 | May 28, 2026 |
|
IWP
iShares Russell Mid-Cap Growth ETF
|
ETF | BlackRock / iShares | 0.08% | $14,844,523.44 | 782,939 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.03% | $12,898,857.72 | 777,508 | Feb 28, 2026 | Apr 24, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.05% | $11,943,920.73 | 719,947 | Feb 28, 2026 | Apr 24, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.05% | $10,398,329.97 | 626,783 | Feb 28, 2026 | Apr 24, 2026 |
|
FSMDX
Fidelity Mid Cap Index Fund
|
MF | Fidelity | 0.02% | $9,285,033.82 | 432,667 | Apr 30, 2026 | Jun 26, 2026 |
|
FCNTX
Fidelity Contrafund
|
MF | Fidelity | 0.01% | $9,273,525.60 | 489,110 | Mar 31, 2026 | May 26, 2026 |
|
IWF
iShares Russell 1000 Growth ETF
|
ETF | BlackRock / iShares | 0.01% | $9,119,361.84 | 480,979 | Mar 31, 2026 | May 22, 2026 |
|
FACTX
Fidelity Advisor Health Care Fund
|
MF | Fidelity | 0.30% | $8,584,000.00 | 400,000 | Apr 30, 2026 | Jun 26, 2026 |
|
IWR
iShares Russell Mid-Cap ETF
|
ETF | BlackRock / iShares | 0.02% | $8,517,988.56 | 449,261 | Mar 31, 2026 | May 28, 2026 |
|
HQH
abrdn Healthcare Investors
|
CEF | abrdn / Aberdeen | 0.71% | $8,098,441.68 | 427,133 | Mar 31, 2026 | May 29, 2026 |
|
VHCIX
VANGUARD HEALTH CARE INDEX FUND
|
ETF | Vanguard | 0.04% | $7,412,329.05 | 446,795 | Feb 28, 2026 | Apr 28, 2026 |
|
FNCMX
Fidelity Nasdaq Composite Index Fund
|
MF | Fidelity | 0.03% | $7,266,071.61 | 437,979 | Feb 28, 2026 | Apr 24, 2026 |
|
SCHM
Schwab U.S. Mid-Cap ETF
|
ETF | Charles Schwab | 0.05% | $6,707,536.08 | 404,312 | Feb 28, 2026 | Apr 24, 2026 |
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
ETF | Direxion | 1.15% | $5,984,056.62 | 278,847 | Apr 30, 2026 | Jun 29, 2026 |
Advertisement (320x50)